SPONSOR
BeBetter Med Inc
Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: Non-Small Cell Lung CancerEGFR Exon 20 Insertion MutationAdvanced Triple-Negative Breast Cancer
NCT06706713 Phase 2
Recruiting
Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
NCT06685796 Phase 2
Recruiting
A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer
Advanced Triple-Negative Breast Cancer